Spindletop Health Acquisition Corp. (SHCAU) Prices $200M IPO

Spindletop Health Acquisition Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SHCAU” Thursday, November 4.

The new SPAC intends to focus its investment efforts broadly across the entire healthcare and healthcare-related industries in the United States, with an emphasis on healthcare services, healthcare information technology, insurance and related products, biotechnology, pharmaceuticals, medical devices, and diagnostics. Spindletop Health is led by CEO and CFO Evan S. Melrose, M.D., Chairman James H. Henry, Secretary Steve Whitlock, SVP of Corporate Development JD Moore, and  COO Kelly Huang, Ph.D.

Total SPAC deal count for 2021 year-to-date is now 519. This offering is expected to close on Monday, November 8.

Barclays and Stifel are acting as the joint book-running managers for this offering. DLA Piper LLP (US) is serving as Issuer’s Counsel with Ropes & Gray LLP serving as Underwriter’s Counsel.  Marcum, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.